Search results

  1. cassava7

    Cognitive dysfunction 1 year after COVID-19: evidence from eye tracking, Carbone et al, 2022

    Increasing evidence suggests persistent cognitive dysfunction after COVID-19. In this cross-sectional study, frontal lobe function was assessed 12 months after the acute phase of the disease, using tailored eye tracking assessments. Individuals who recovered from COVID-19 made significantly...
  2. cassava7

    Are objective outcomes of cognitive function possible?

    I also came across this: https://med-mastodon.com/@CastlTrAstonDrs/109313935213337419 “#Neurology Increasing evidence suggests persistent cognitive dysfunction #LongCovid .In this cross-sectional study, frontal lobe function was assessed 12 months after the acute phase of the disease, using...
  3. cassava7

    Pain researchers lose three papers after Cochrane group questioned data, Retraction Watch

    Two interesting parts in the article above: “extremely large effect sizes at both short and long-term follow up, (which is something that is really not common in the field of chronic pain and certainly not seen in other trials of CBT),” — Neil O’Connell, coordinating editor for the Cochrane...
  4. cassava7

    Are objective outcomes of cognitive function possible?

    The duration of testing is essential. We have seen multiple long Covid studies where two or three short tests from the NIH toolbox were used and revealed no cognitive impairment. In Norway, Wyller recently published a similar study in teenagers with ME/CFS. My neuropsychological (cognitive)...
  5. cassava7

    Suppose you have €5-10 million for ME/CFS research, what would you spend it on?

    Epidemiological studies are indeed paramount to better understanding ME/CFS and emphasizing its scale at a societal level. However, once the results are in, they must be acted on and this requires the involvement of politicians. It would seem wise to set aside some money for political lobbying...
  6. cassava7

    Study finds first direct evidence of a link between low serotonin and depression

    Note that if one outlier is removed from the results, they are no longer significant:
  7. cassava7

    Norway: Article about ME seminar with security

    Vogt’s response is truly strange. What is Recovery Norway other than a movement, given their lobbying activities? He would be very quick to label the Norwegian ME association as such, but it seems he has double standards. RN may not be a wealthy organization, but it has been funded enough to...
  8. cassava7

    What is the quality of life in patients with long COVID compared to a healthy control group? 2022, Liska et al

    Yet another study showing that the SF-36 physical function questionnaire threshold of 60 in the PACE trial is indefensible. Subtracting one standard deviation from the mean of the healthy group yields 85.5 as the recovery score.
  9. cassava7

    In progress: Rehabilitation Therapy for Post COVID 19 Chronic Fatigue Syndrome, 2022 -

    “Patients will be selected using the Oxford diagnostic criteria for CFS…” Truly a PACE 2.0.
  10. cassava7

    Germany: IQWIG Report to government on ME/CFS - report out now May 2023

    We discussed the 80% threshold a few pages back — I believe it was @Pustekuchen who showed that IQWiG followed their methodological guideline and did not arbitrarily choose the 80% inclusion threshold.
  11. cassava7

    Lancet - Long COVID: An opportunity to focus on post-acute infection syndromes

    It is pleasantly surprising to see such an editorial in a Lancet journal (The Lancet Regional Health — Europe).
  12. cassava7

    Any good science on problems taking Vitamin B12?

    I imagine that we should be aware of B12 deficiency in ME/CFS by now if it were a problem. However, given that it can cause anemia and thus profound fatigue, it may not be surprising to see people with B12 deficiency misdiagnosed with ME/CFS if they have not been tested for it. Additionally, I...
  13. cassava7

    Science has a Nasty Photoshopping Problem. Elisabeth Bik, NYT

    Perhaps the most important aspect of this article is that Dr Bik explained the background context which incites researchers to cheat in simple terms. If someone were not aware of the problems with academia, I would direct them towards this article.
  14. cassava7

    [Preprint] A mind-body interface alternates with effector-specific regions in motor cortex, Gordon et al, 2022

    One of the authors made this point: “Mind” in this work is presumably to be understood as “planning voluntary movement”.
  15. cassava7

    [Preprint] A mind-body interface alternates with effector-specific regions in motor cortex, Gordon et al, 2022

    Surely, textbook rewrite worthy discoveries such as this work (Penfield’s motor homonculus model dates from 1948) should prompt neurologists and psychiatrists to remain humble about our limited knowledge of the brain.
  16. cassava7

    [Preprint] A mind-body interface alternates with effector-specific regions in motor cortex, Gordon et al, 2022

    Primary motor cortex (M1) has been thought to form a continuous somatotopic homunculus extending down precentral gyrus from foot to face representations. The motor homunculus has remained a textbook pillar of functional neuroanatomy, despite evidence for concentric functional zones and maps of...
  17. cassava7

    Tonsils, Appendixes, Gall Bladders and ME/CFS

    I am not aware of any such research, but like other infectious diseases, tonsillitis, appendicitis and cholecystitis caused by pathogens may well trigger ME. As for the appendix, I have anecdotally heard that it serves as a reservoir of good bacteria for the gut. I do not know whether this is...
  18. cassava7

    Diagnosis of mast cell activation syndrome: a global “consensus-2”, 2020, Afrin et al

    I talked briefly with a clinical lead consultant in allergology and expert for the French Health and Food Security Agency. He mentioned that he has seen about 10 cases of MCAS in almost 3 decades (as diagnosed by serum tryptase and urinary metabolites of histamine, i.e. as per the AAAAI /...
  19. cassava7

    Diagnosis of mast cell activation syndrome: a global “consensus-2”, 2020, Afrin et al

    In essence, this consensus statement (which mostly included clinicians and few researchers) is a rebuttal of the restrictive “consensus-1” diagnostic criteria that were established by mastocytosis experts (Valent et al 2010), which are as follows per their 2019 update: The authors mainly...
Back
Top Bottom